X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
statistics & probability (40) 40
index medicus (37) 37
mathematical & computational biology (28) 28
medicine, research & experimental (27) 27
continual reassessment method (26) 26
models, statistical (25) 25
medical informatics (24) 24
public, environmental & occupational health (23) 23
clinical trials (22) 22
article (21) 21
maximum tolerated dose (20) 20
dose-response relationship, drug (18) 18
cancer (17) 17
clinical trials, phase i as topic - methods (17) 17
computer simulation (17) 17
research design (13) 13
toxicity (12) 12
clinical-trials (11) 11
design (11) 11
bayes theorem (8) 8
biometrics (8) 8
biostatistics (8) 8
data interpretation, statistical (8) 8
dose-finding studies (8) 8
escalation (8) 8
proportional hazards models (8) 8
algorithms (7) 7
dose escalation (7) 7
female (7) 7
i clinical-trials (7) 7
oncology (7) 7
analysis (6) 6
antineoplastic agents - administration & dosage (6) 6
biology (6) 6
designs (6) 6
dose finding (6) 6
dose‐finding studies (6) 6
likelihood functions (6) 6
methods (6) 6
phase 1 trials (6) 6
phase i trials (6) 6
phase-i (6) 6
regression analysis (6) 6
sample size (6) 6
simulation (6) 6
computer science, interdisciplinary applications (5) 5
dose-finding (5) 5
neoplasms - drug therapy (5) 5
proportional hazards model (5) 5
statistics (5) 5
survival analysis (5) 5
treatment outcome (5) 5
adult (4) 4
approximation (4) 4
breast cancer (4) 4
clinical trial (4) 4
clinical trials, phase i as topic - statistics & numerical data (4) 4
confidence intervals (4) 4
dosage (4) 4
dose‐finding (4) 4
inference (4) 4
maximum likelihood estimation (4) 4
meta-analysis as topic (4) 4
middle aged (4) 4
models (4) 4
pharmacology (4) 4
pharmacology & pharmacy (4) 4
research (4) 4
antineoplastic agents - therapeutic use (3) 3
breast neoplasms - mortality (3) 3
calibration (3) 3
censorship (3) 3
dependence (3) 3
dose finding studies (3) 3
drug-related side effects and adverse reactions (3) 3
efficacy (3) 3
experimentation (3) 3
life sciences (3) 3
linear models (3) 3
male (3) 3
mathematics, applied (3) 3
mathematics, interdisciplinary applications (3) 3
meta-analysis (3) 3
modeling (3) 3
mortality (3) 3
null hypothesis (3) 3
parametric models (3) 3
pharmacokinetics (3) 3
phase i (3) 3
randomized controlled trials as topic - statistics & numerical data (3) 3
regression (3) 3
santé publique et épidémiologie (3) 3
splines (3) 3
statistical methods (3) 3
survival (3) 3
time factors (3) 3
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (2) 2
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (2) 2
aged (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Statistics in Medicine, ISSN 0277-6715, 10/1999, Volume 18, Issue 20, pp. 2683 - 2690
Journal Article
Annals of Epidemiology, ISSN 1047-2797, 10/2017, Volume 27, Issue 10, pp. 672 - 676
Journal Article
Journal Article
NATURE REVIEWS CLINICAL ONCOLOGY, ISSN 1759-4774, 11/2015, Volume 12, Issue 11, pp. 626 - 628
Dose-expansion cohorts (DECs) enable investigators to identify potentially effective drugs, for specific patient populations, in a single trial by assessing... 
DESIGN | ONCOLOGY | SAFETY | I TRIALS | CANCER | Dose-response relationship (Biochemistry) | Pharmaceutical research | Clinical trials | Drug discovery | Research | Methods
Journal Article
Biometrics, ISSN 0006-341X, 06/2017, Volume 73, Issue 2, pp. 483 - 494
Journal Article
Journal Article
2006, 2nd ed., ISBN 0824723392, 617
Book
Statistics in Biopharmaceutical Research, ISSN 1946-6315, 04/2014, Volume 6, Issue 2, pp. 185 - 197
The idea of bridging in dose-finding studies is closely linked to the problem of group heterogeneity. There are some distinctive features in the case of... 
Dose escalation | Continual reassessment method | Toxicity | Phase 1 trials | Clinical trials | Calibration | Pediatric trials | Pharmacokinetics | STATISTICS & PROBABILITY | CANCER | DESIGNS | CLINICAL-TRIALS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Bridging | Dose finding studies | Continual Reassessment Method
Journal Article